Ranibizumab 10 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 10 mg/mL
Reference Brands: Lucentis (USA/EU)
Category: Opthalmology
Ranibizumab is a Opthalmology product available as Injection in strengths 10 mg/mL. It corresponds to the reference brand Lucentis (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Ranibizumab is a vascular endothelial growth factor (VEGF-A) inhibitor used to manage and treat a variety of retinal disorders caused by abnormal blood vessel growth. Its approved indications include neovascular age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), myopic choroidal neovascularization, and diabetic retinopathy.
Ranibizumab works by binding to VEGF-A, preventing it from stimulating the formation of new blood vessels in the retina. This action reduces fluid leakage, limits retinal damage, and helps slow the progression of vision loss. Administered as a sterile intravitreal injection, ranibizumab requires careful monitoring to ensure safety and efficacy, including assessment of ocular and systemic adverse events.
Its well-established mechanism, targeted therapeutic effect, and wide range of ocular indications make ranibizumab a cornerstone in the management of retinal vascular diseases. Proper understanding of its pharmacodynamics, pharmacokinetics, dosing, adverse effect profile, and contraindications enables healthcare professionals to optimize patient outcomes in ophthalmology.
Ranibizumab — third party manufacturing & bulk supply
Ranibizumab 10 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Ranibizumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ranibizumab →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ranibizumab is used to treat retinal vascular disorders, including wet age‑related macular degeneration (AMD), diabetic macular edema (DME), macular edema following retinal vein occlusion (RVO), and diabetic retinopathy by inhibiting VEGF and reducing abnormal blood vessel growth.
The active ingredient is ranibizumab, a recombinant humanized monoclonal antibody fragment targeting VEGF‑A. It is formulated as a sterile solution for intravitreal injection.
The most recognized trade name is Lucentis®.
Ranibizumab is produced by licensed biopharmaceutical manufacturers that hold marketing authorizations for Lucentis® and biosimilar ranibizumab products in various regions.
The generic name is Ranibizumab.
Brand examples include Lucentis® and related biosimilar products.
Ranibizumab is manufactured in GMP‑certified biopharmaceutical facilities globally, ensuring quality and sterility for intravitreal use.
Related Products
Artificial Tears
Strength:
0.3% to 1%
Form: Eye Drops/ Eye Gel/ Eye ointment
Reference Brands: Refresh Tears (USA/LATAM), Hylo-Tear (EU), Refresh Liquigel (India)
View Details
Tetrahydrozoline Hydrochloride
Strength:
0.05%
Form: Eye Drops
Reference Brands: Visine (USA/EU / LATAM), Ocuvis (India)
View Details
Quick Response Guaranteed | Verified Suppliers
